Consultancy
Leadership: Don’t Waste Your Time - Workshop for Scale-up Leaders by Horizon37
The signature “Don’t Waste Time” workshop, the foundation of the HorizonMethod, teaches you to say NO more than say YES, deprioritise ruthlessly and focus on driving positive business results. ...
Click start your marketing in 2024
With our screens already showing adverts that fill us with the joys of Christmas (well done Morrisons & Boots, better luck next year M&S), and mince pies already elbowing their way onto the shelves of our supermarkets, it's time to start shifting our focus to 2024’s marketing ch...
How to find the small actions that deliver big impact (with no rocket science needed!)
In our recent webinar, Acteon’s Owen Rose and Rebecca Trigg delved into a five-step approach for finding the ‘smart moves’ to achieve impact and successfully drive change in your organisation. They shared real world experiences and solutions, divulging how to apply each ste...
Unleashing the potential of Micro 3D Printing with the BMF PµSL System
IPFL is at the forefront of micro 3D printing innovation with the BMF PµSL system, offering unparalleled precision in manufacturing microscale components. Ideal for aerospace, medical, and electronics industries, this advanced technology enables the creation of highly detailed parts pre...
How well equipped are you to lead change?
Chris Dunn writes...Leading change is one of the most challenging aspects of leadership. This is not only because the pace of change is accelerating but also because so much seems to be changing all at the same time. So, where do leaders and senior managers get the right support to hel...
3 Steps for cell & gene therapy medical affairs teams to provide strategic value
A phrase often recited within the pharmaceutical and biotechnology industries in recent years is that medical affairs is the third strategic pillar of success, along with R&D and commercial. Ongoing advancements in the cell and gene therapy sector have further highlighted the critic...
The Paradigm Shift: Navigating the emergence of value-based contracts for future gene therapies
Value-based contracting (VBC) has been difficult to execute in the pharmaceutical arena, especially in the gene therapy space. This has been driven by several factors, including the lack of long-term data, the imbalance of upside and downside risk between manufacturers and payers, and d...
A longitudinal perspective on innovation
There is growing interest in the innovation process in the biopharmaceutical industry, with particular public scrutiny around the composition of research and development (R&D) spending and the role of intellectual property. This process is commonly characterized as involving a mixtu...
Oncology vaccines: Are they positioned for PMA success?
With combinations taking center stage following the initial influx of immune checkpoint inhibitor monotherapies, the authors look ahead to the potential of mRNA vaccines in oncology and describe the pricing and market access opportunities and challenges that may await current and future...
The burden of non-specific pain disorder in US women
Based on existing evidence on the delay, lack of recognition, and burden of pain conditions commonly afflicting women (specifically endometriosis, PCOS, fibromyalgia, IBS or migraines), CRA sought to understand how being diagnosed with these conditions impacts women’s mental health and ...